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Research article Salvianolic acid B prevents 
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TGF-β1 signal transduction pathway in vivo and in 
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Abstract
Background: Salvianolic Acid B (Sal B) is a water-soluble component from Danshen (a traditional Chinese herb widely 
used for chronic renal diseases) with anti-oxidative and cell protective properties. Sal B also has potential protective 
effects on renal diseases. Tubular epithelial cells can undergo epithelial-to-mesenchymal transition (EMT), which plays 
an important role in the pathogenesis of renal interstitial fibrosis (RIF) and is mainly regulated by TGF-β1/Smads 
pathway. The aims of the study are to investigate the effect of Sal B on tubular EMT in vivo and in vitro, and to elucidate 
its underlying mechanism against EMT related to TGF-β1/Smads pathway.
Results: For in vivo experiments, RIF was induced in rats by oral administration of HgCl2 and prophylaxised with Sal B 
and vitamin E. The protein expression of E-cadherin was down-regulated, while the expression of α-SMA, TGF-β1, TβR-I, 
p-Smad2/3 and the activity of matrix metalloproteinase-2 (MMP-2) were up-regulated in kidneys of model rats when 
compared with those of normal rats. In contrast, Sal B and vitamin E significantly attenuated the expression of α-SMA, 
TGF-β1, TβR-I, p-Smad2/3, and MMP-2 activity, but increased E-cadherin expression. For in vitro experiments, HK-2 cells 
were incubated with TGF-β1 to induce EMT, and the cells were co-cultured with 1 and 10 μM Sal B or SB-431542 (a 
specific inhibitor of TβR-I kinase). TGF-β1 induced a typical EMT in HK-2 cells, while it was blocked by Sal B and SB-
431542, as evidenced by blocking morphologic transformation, restoring E-cadherin and CK-18 expression, inhibiting 
α-SMA expression and F-actin reorganization, and down-regulating MMP-2/9 activities in TGF-β1 mediated HK-2 cells. 
Furthermore, Sal B and SB-431542 profoundly down-regulated the expressions of TβR-I and p-Smad2/3 but prevented 
the decreased expression of Smad7 in TGF-β1 stimulated HK-2 cells.
Conclusions: Sal B can prevent tubular EMT in the fibrotic kidney induced by HgCl2 as well as HK-2 cells triggered by 
TGF-β1, the mechanism of Sal B is closely related to the regulation of TGF-β1/Smads pathway, manifested as the 
inhibition of TGF-β1 expression, suppression of TβR-I expression and function, down-regulation of Smad2/3 
phosphorylation, and restoration of the down-regulation of Smad7, as well as inhibition of MMP-2 activity.
Background
Renal interstitial fibrosis (RIF) is a common manifesta-
tion in progressive renal diseases leading to functional
deterioration and eventual loss of renal function, irre-
spective of the nature of the initial renal injury [1]. Acti-
vation of tubulointerstitial myofibroblast leads to the
production of excessive extracellular matrix with a pre-
dominance of interstitial collagens, and plays a critical
role in the progression of chronic renal diseases [2].
Emerging evidence suggests that myofibroblasts can be
derived from tubular epithelial cells through the process
of epithelial-to mesenchymal transition (EMT) during
the progression to renal fibrosis [3]. Transforming growth
factor-beta1 (TGF-β1) has been proposed to be the major
regulator in inducing EMT and renal fibrosis [4], mainly
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via the TGF-β/Smads signal transduction pathway [5].
Despite EMT contributes to the disease progression, sev-
eral studies have suggested that EMT of the tubular epi-
thelial cell can be reversible [6].
Danshen (Radix Salviae Miltiorrhizae, SM) is a popular
traditional Chinese herb widely used in treating cardio-
vascular, renal, and hepatic diseases by improving circu-
lation and resolving stasis [7,8]. Salvianolic acid B (Sal B)
(Figure 1), also known as lithospermates B or tanshinoate
B, is a major water soluble component extracted from
SM, which was well recognized as an antioxidative agent
and free radical scavenger, involved in the protection of
various cells, including nerve cells and hepatocytes [9-
12]. It was reported that SM and its aqueous extract, Sal
B, produced a good effect in treating patients and animals
with chronic renal diseases. They could improve renal
function in uremic rats through the activation of kallirein
and the promotion of prostaglandin E2 production [13-
15]. Moreover, recent research showed that Sal B can pre-
vent TGF-β1-induced EMT of human kidney cell lines in
vitro [16]. Our previous studies showed that Sal B had
obvious therapeutic effects against liver fibrosis in
patients with chronic hepatitis B [17] and animal models
induced by dimethylnitrosamine [18], and its mechanism
was closely associated with the inhibition of hepatic stel-
late cell activation through the regulation of TGF-β/
Smads signaling [19]. Moreover, our recent study found
that Sal B can prevent RIF induced by mercuric chloride
(HgCl2) in rats, with the mechanism associated with anti-
oxidative injury [20].
Although the pivotal role of tubular EMT in RIF is
widely accepted [21], a recent controversial report dis-
cussing the epithelial origin for myofibroblast in vivo [22]
suggests that EMT in vivo may be different from EMT in
vitro. Therefore it is definitely worthwhile to evaluate the
effect of Sal B on tubular EMT in vivo as well as in vitro
and probe its underlying mechanism of action in order to
obtain more solid evidence of Sal B's action on tubular
EMT and better understand its mechanism. In this study,
we observed the effects of Sal B on renal tubular EMT in
vivo  and  in vitro and investigated Sal B's underlying
mechanism of action against EMT in renal tubular epi-
thelial cells relating to the TGF-β/Smads signal pathway.
The results demonstrate that Sal B can prevent tubular
EMT in the fibrotic kidney induced by HgCl2 as well as
human proximal tubular epithelial cells (HK-2 cell line)
after being triggered by TGF-β1. The mechanism of
action is closely related to the regulation of the TGF-β1
signaling pathway via the inhibition of TGF-β1 expres-
sion, suppression of TGF-β type I receptor (TβR-I)
expression and function, down-regulation of Smad2/3
phosphorylation, and restoration of the down-regulation
of Smad7 by TGF-β1, as well as the inhibition of matrix
metalloproteinase 2 (MMP-2) activity in diseased kid-
neys.
Results
1. Sal B ameliorated renal interstitial fibrosis induced by 
HgCl2 in rats
The excessive and disorganized deposition of collagens is
a major pathogenic feature of fibrotic diseases. HgCl2
induced an increased amount of collagen formation in
the Masson's trichrome-stained kidney sections. In con-
trast, collagen levels diminished in Sal B and Vitamin E
(Vit E) treated fibrotic kidneys (Figure 2A.).
Hydroxyproline (Hyp) content is a specific marker for
collagen synthesis. The results showed that Hyp content
Figure 1 The chemical structure of Sal B.
Figure 2 Sal B ameliorated renal interstitial fibrosis induced by 
HgCl2 in model rat. (A) Masson's trichrome staining for assessing renal 
interstitial fibrosis. HgCl2 induced an increase of collagen in kidney sec-
tion. Sal B and Vit E treatments reduced collagen deposition. (B) Kidney 
Hyp content determined by Jamall's method. Hyp content of kidneys 
was increased significantly in the model group as compared with the 
normal group. In contrast, Sal B and Vit E treatments significantly de-
creased kidney Hyp content.
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in kidney increased significantly in the model group
when compared with the normal group. In contrast, Sal B
and Vit E treatments significantly decreased kidney Hyp
content of model rats. There was no significant difference
in Hyp content between Sal B and Vit E groups (Figure
2B.).
2. Effects of Sal B on the expressions of alpha smooth 
muscle actin (α-SMA) and E-cadherin in kidneys of model 
rats
Immunohistochemistry analysis revealed that the expres-
sion of α- SMA was very weak in t he renal tubule and
interstium of normal kidneys, whereas it was prominent
in model rats. On the other hand, epithelial cell marker,
E-cadherin, was markedly decreased in the tubular epi-
thelium of model groups compared with the normal
group. Sal B treatment attenuated the increased expres-
sion of α-SMA in fibrotic kidneys. Moreover, E-cadherin
expression was maintained in response to Sal B treatment
(Figure 3A). Therefore, the disruption of the tubular
basement membrane was ameliorated with Sal B treat-
ment. Vit E had the same effects. This observation may
indicate that Sal B inhibits the process of EMT in fibrotic
kidneys, as characterized by the transition from the epi-
thelial to the mesenchymal phenotype.
Consistent with the immunohistochemistry studies,
Western blot analysis revealed increased α-SMA and
decreased E-cadherin expression in the kidneys of model
group rats when compared with the normal group. In
contrast, Sal B and Vit E treatments significantly inhib-
ited the up-regulation of α-SMA and the down-regulation
of E-cadherin. Howerer, the effect of Sal B was signifi-
cantly more pronounced than Vit E. (Figure 3B, C).
3. Sal B treatment attenuated the increase in TGF-β1, TβR-I, 
and Smad2/3 phosphorylation in kidneys of model rats
TGF-β1/Smads signaling is known to play a major role in
the process of TGF-β1-induced EMT. The results demon-
strated that there was no significant change in Smad2 and
Smad3 expression between each group, while the expres-
sion of phosphorylated Smad2 and Smad3, TGF-β1, and
TβR-I was significantly increased in kidneys of rats in the
model group when compared with those of the normal
group. Conversely, Sal B treatments significantly attenu-
ated the up-regulation of TGF-β1, TβR-I, p-Smad2, and
p-Smad3 (Figure 4).
4. Sal B down-regulated the activity of MMP-2 in kidneys of 
model rats
Disruption of the tubular basement membrane (TBM) is
a key event essential for EMT at the cellular level, and
MMP-2 can degrade TBM proteins such as type IV colla-
gen, leading to the initiation of tubular EMT. The activity
of MMP-2 in kidney tissue was assessed using gelatin
zymography. As shown in Figure 5, the activity of MMP-2
was increased in rats of the model group when compared
with that of the normal group. Sal B and Vit E signifi-
cantly down-regulated the activity of MMP-2. (Figure 5.)
5. Effects of Sal B on cell viability and toxicology of HK-2 
cells
Cell viability was determined by the alamarBlue assay.
The results were expressed as the percentage of reduction
in alamarBlue. 1 μM and 10 μM of Sal B had no signifi-
cant effect (P > 0.05) on cell viability during each incuba-
tion period, whereas 100 μM of Sal B decreased the
viability of HK-2 cells by 11% (P < 0.05) and 20% (P <
0.05) when compared to control cells after 12 h and 24 h
of incubation, respectively (Figure 6A).
To investigate the cytotoxicity of Sal B on HK-2 cells,
cells were treated with a wide range of Sal B doses from 1
μM to 100 μM. After 24 h of incubation, we found no
Figure 3 The Effects of Sal B on α-SMA and E-Cadherin expression 
in kidneys of model rats. (A) Immunofluorescence staining of α-SMA 
and E-cadherin in kidneys. Increased labeling of α-SMA in the tubule 
was observed in model rats, while it was noted to be decreased by Sal 
B treatment. The E-cadherin labeling intensity was decreased in model 
rats, whereas the intensity was maintained in the Sal B treatment 
group (B) Western blot analyses for α-SMA and E-cadherin expression 
in renal tissues. Significantly increased α-SMA expression and de-
creased E-cadherin expression were observed in rats of the model 
group. Sal B treatment attenuated HgCl2-induced upregulation of α-
SMA expression. Moreover, it significantly inhibited the HgCl2-induced 
decrease of E-cadherin expression. (C) Graphic presentation of the rel-
ative expression of α-SMA and E-cadherin. The values are represented 
as the density of α-SMA or E-cadherin vs GAPDH (%). **P < 0.01 vs nor-
mal; *P < 0.05 vs normal; #P < 0.05 vs Model; # #P < 0.01 vs Model.
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Figure 4 The Effect of Sal B on TGF-β1, TβRI, Smad2, p-Smad2 and p-Smad3 expression in kidneys of model rats. Western blot analysis 
showed significantly increased TGF-β1, TβR-I, p-Smad2 and p-Smad3 expressions in rats of the model group. In contrast, Sal B treatment attenuated 
HgCl2-induced upregulation of TGF-β1, TβR-I, p-Smad2 and p-Smad3 expressions. The values are represented as the density of TGF-β1 or TβR-I vs. 
GAPDH (%), or p-Smad2 vs. Smad2 (%), or p-Smad3 vs. Smad3 (%). **P < 0.01 vs. normal; *P < 0.05 vs. normal; ## P < 0.01 vs. model; #P < 0.05 vs. model.
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Figure 5 The effect of Sal B on the activity of MMP-2 in kidneys of model rats. The activity of MMP-2 was assessed by gelatin zymography. The 
results showed the activity of MMP-2 was increased in rats of model group when compared with that of normal group. Sal B significantly down-reg-
ulated the activity of MMP-2. **P < 0.01 vs. normal; # P < 0.05 vs. Model.
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Figure 6 Effects of Sal B on cell viability and toxicology in HK-2 cells. (A) Cell viability was determined by the alamarBlue assay. The results were 
expressed as a percentage in the reduction of alamarBlue. 1 μM and 10 μM of Sal B had no significant effect (P > 0.05) on cell viability during each 
incubation time period, whereas 100 μM of Sal B decreased the viability of HK-2 cells by 11% (P < 0.05) and 20% (P < 0.05), when compared with control 
cells after 12 h and 24 h of incubation, respectively. (B) Cell toxicology was determined by high content screening (HCS) assay. HK-2 cells were plated 
in a 96-well plate at a density of 4,000 cells/well. Cells were incubated with 1-100 μM of Sal B for 24 h and then stained with 1 × MPCT1 Fluor Dye. Cell 
images from the various fluorescent dye stains were taken by HCS (×200). There were no obvious changes in nuclear morphology, membrane per-
meability, or lysosomal mass/pH after incubation with 1 μM and 10 μM of Sal B when compared with control cells. However, 100 μM of Sal B presented 
as an obvious cytotoxicity to cells. As shown by the indicator dye, there are fewer nuclei and an increase in membrane permeability.
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Figure 7 The effects of Sal B on E-cadherin mRNA expression, cell morphologic transformation and F-actin reorganization induced by 
TGF-β1 in HK-2 cells. (A) The effects of Sal B on E-cadherin mRNA expression. Real-time PCR analysis showed that TGF-β1 significantly suppressed 
E-cadherin mRNA expression in HK-2 cells, while 1 μM and 10 μM of Sal B prevented the loss of its expression (B) The effects of Sal B on cell mor-
phology transformation and F-actin reorganization. HK-2 cells were incubated with serum-free medium or treated with (1) 2.5 ng/ml TGF-β1, (2) 
2.5 ng/ml TGF-β1 plus 1 μM of Sal B, (3) 2.5 ng/ml TGF-β1 plus 10 μM of Sal B, (4) 2.5 ng/ml TGF-β1 plus 10 μM of SB-431542 for 24 h. HK-2 cells 
changed from a cuboidal to a spindle shape in response to TGF-β1, whereas treatment with 1 μM and 10 μM Sal B and SB-431542 blocked this 
morphologic transformation (×200). Representative micrographs of FITC-conjugated phalloidin staining showed significanat F-actin reorganiza-
tion and the formation of abundant long stress fibers in HK-2 cells induced by TGF-β1 were formed. 1 μM and 10 μM of Sal B and SB-431542 sig-
nificantly blocked these processes.
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Figure 8 Sal B depressed CK-18 expression induced by TGF-β1 in HK-2 cells. HK-2 cells were cultured in complete medium containing 5% FBS 
for 18 h. Thereafter, the cells were kept in serum-free medium or treated with (1) 2.5 ng/ml TGF-β1, (2) 2.5 ng/ml TGF-β1 plus 1 μM of Sal B, (3) 2.5 ng/
ml TGF-β1 plus 10 μM of Sal B, (4) 2.5 ng/ml TGF-β1 plus 10 μM of SB-431542 for 24 h. (a) Immunofluorescence staining (×200) showed decreased 
immunolabeling intensity of CK-18 after TGF-β1 treatment. This effect was depressed by 1 μM and 10 μM of Sal B as well as SB-431542 treatments. The 
blue-colored stain is nuclear counterstaining with Hoechst 33258. (B) Western blot analysis for CK-18. CK-18 expression was decreased when cells were 
exposed to TGF-β1, whereas 1 μM and 10 μM of Sal B and SB-431542 significantly attenuated the TGF-β1-induced up-regulation of α-SMA. (C) Graphic 
presentation of the relative expression of CK-18. The values are represented as 100% vs. control. **P < 0.01 vs. control; #P < 0.05 vs. TGF-β1, # #P < 0.01 
vs. TGF-β1.
 
GAPDH 37kd 
CK-18 45kd 
C K - 1 8               N u c l e u s               M e r g e  
C
o
n
t
r
o
l
 
 
 
 
 
 
 
 
 
 
T
G
F
-
 
1
 
 
 
 
 
 
 
 
 
 
 
T
G
F
-
 
1
+
1
 
M
 
S
a
l
 
B
 
 
 
 
T
G
F
-
 
1
+
1
0
 
M
 
S
a
l
 
B
 
 
 
T
G
F
-
 
1
+
S
B
-
4
3
1
5
4
2
 
TGF- 1                              
1 M Sal B                                
10 M Sal B                              
SB-431542                           
(A) 
(B) (C) 
0
25
50
75
100
Control TGF- 1 1 M Sal B 10 M SalB SB-431542
C
K
-
1
8
 
˄
%
 
v
s
.
 
G
A
P
D
H
)
#
**
## ##Wang et al. BMC Cell Biology 2010, 11:31
http://www.biomedcentral.com/1471-2121/11/31
Page 8 of 16
Figure 9 Sal B blocked α-SMA expression induced by TGF-β1 in HK-2 cells. HK-2 cells were cultured in complete medium containing 5% FBS for 
18 h. Thereafter, the cells were kept in serum-free medium or treated with (1) 2.5 ng/ml TGF-β1, (2) 2.5 ng/ml TGF-β1 plus 1 μM of Sal B, (3) 2.5 ng/ml 
TGF-β1 plus 10 μM of Sal B, (4) 2.5 ng/ml TGF-β1 plus 10 μM of SB-431542 for 24 h. (A) Immunofluorescence staining (×200) shows the increased la-
beling intensity of α-SMA observed after TGF-β1 treatment, while its increase becomes reversed after 1 μM and 10 μM Sal B and SB-431542 treatments. 
The blue-colored stain is nuclear counterstaining with Hoechst 33258. (B) Western blot analysis for α-SMA. α-SMA expression was increased when the 
cells were exposed to TGF-β1, whereas treatment with 1 μM and 10 μM Sal B and SB-431542 significantly attenuated the up-regulation of α-SMA by 
TGF-β1. (C) Graphic presentation of the relative expression of α-SMA. The values are represented as 100% vs. GAPDH. **P <0.01 vs. control; # #P < 0.01 
vs. TGF-β1.
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obvious changes in nuclear morphology, membrane per-
meability, or lysosomal mass/pH with 1 μM and 10 μM of
Sal B treatments in comparison with control cells. How-
ever, 100 μM of Sal B showed an obvious cytotoxicity to
cells, reflected by fewer nuclei and an increase in the
membrane permeability as shown by the indicator dye.
Therefore, 1 μM and 10 μM of Sal B were considered to
be safe doses for treating cells (Figure 6B).
6. Sal B treatment blocked TGF-β1-induced EMT in HK-2 
cells
(1) Sal B prevented the loss of E-Cadherin and Cytokeratin-18 
(CK-18) expressions and inhibited α-SMA expression induced 
by TGF-β1 in HK-2 cells
E-cadherin is a tubular epithelial cell-cell adhesion recep-
tor that is essential for the formation and maintenance of
renal epithelial homeostasis and architecture [23,24]. We
found that TGF-β1 significantly suppressed E-cadherin
mRNA expression in HK-2 cells, while 1 and 10 μM of Sal
B prevented the loss of its expression (Figure 7A).
Consistent with the alteration in E-cadherin mRNA
expression, both immunofluorescence and Western blot
analyses showed that CK-18, an epithelial cell marker,
was significantly down-regulated after TGF-β1 treatment
and was then reversed by 1 μM and 10 μM of Sal B treat-
ments (Figure 8).
On the other hand, α-SMA (a specific myofibroblast
marker) expression was increased significantly after TGF-
β1 incubation, as detected by immunofluorescence and
W estern blot analyses, while 1 μM and 10 μM of Sal B
treatments significantly attenuated its expression (Figure
9).
(2) Sal B blocked the transformation of cell morphology and 
F-actin reorganization induced by TGF-β1
Concomitant with the alterations in E-cadherin, CK-18,
and α-SMA expressions as described above, we found
that 1 μM and 10 μM of Sal B blocked tubular epithelial
cells from taking on a myofibroblastic appearance
induced by TGF-β1. HK-2 cells possess a cobblestone
appearance when grown in culture, but they become
elongated and take on a spindle shape in response to
TGF-β1. Co-incubation of Sal B with TGF-β1 restored
the epithelial morphology of these cells (Figure 7B).
The actin cytoskeleton plays an important role in defin-
ing cell shape and morphology [25]. In this study, we also
examined F-actin reorganization during the conversion
from tubular epithelium to myofibroblasts after TGF-β1
administration. The results revealed that TGF-β1
induced significant F-actin reorganization, forming abun-
dant long stress fibers in HK-2 cells. 1 μM and 10 μM of
Sal B blocked these processes (Figure 7B).
(3) Sal B down-regulated MMP-2 and MMP-9 activation 
induced by TGF-β1 in HK-2 cells
TGF-β1 can promote MMP-2 and MMP-9 activation in
mesangial cells and fibroblasts, and augment tissue
remodeling and fibrogenesis [26,27]. In this study, Zymo-
graphic analysis of conditioned media indicated that
TGF-β1 induced pro-MMP-2 and its activation, as well as
Figure 10 Sal B down-regulated MMP-2 and MMP-9 activation in-
duced by TGF-β1 in HK-2 cells. HK-2 cells were incubated with se-
rum-free medium or treated with (1) 2.5 ng/ml TGF-β1, (2) 2.5 ng/ml 
TGF-β1 plus 1 μM Sal B, (3) 2.5 ng/ml TGF-β1 plus 10 μM Sal B, (4) 2.5 
ng/ml TGF-β1 plus 10 μM SB-431542 for 24 h. The activation of MMP-2 
and MMP-9 derived from cells in the conditioned media were analyzed 
by gelatin zymographic analysis. The results show that TGF-β1 induced 
pro-MMP-2, the activation of pro-MMP-2, and MMP-9 secretion. 1 μM 
Sal B, 10 μM Sal B, and SB-431542 significantly decreased the secretion 
of these MMPs after being induced by TGF-β1. The values are as shown 
as folds vs. Control. **P < 0.01 vs. control; # #P < 0.01 vs. TGF-β1.
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Figure 11 Sal B attenuated TGF-β1-induced TβR-I and Smad2/3 phosphorylation and up-regulated Smad7 expression in HK-2 cells. HK-2 
cells were incubated with serum-free medium or treated with (1) 2.5 ng/ml TGF-β1, (2) 2.5 ng/ml TGF-β1 plus 1 μM of Sal B, (3) 2.5 ng/ml TGF-β1 plus 
10 μM of Sal B, (4) 2.5 ng/ml TGF-β1 plus 10 μM of SB-431542 for 24 h. The expression of TβR-I, Smad2, Smad3, p-Smad2/3 and Smad7 was detected 
by Western Blot. There was no significant change between each group in Smad2/3, but the expression of phosphorylated Smad2/3 and TβR-I was 
significantly increased. Smad7 expression was decreased after incubation with TGF-β1. Treatment with 1 μM and 10 μM Sal B and SB-431542 signifi-
cantly attenuated the TGF-β1-induced up-regulation of p-Smad2/3 and TβR-I and increased Smad7 expression. The values are represented as the den-
sity of p-Smad2/3, TβR-I or Smad7 vs. GAPDH (%). **P < 0.01 vs. control; #P < 0.05 vs. TGF-β1, # #P < 0.01 vs. TGF-β1.
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MMP-9 secretion. 1 μM and 10 μM of Sal B significantly
decreased MMP-2/9 activities. (Figure 10).
7. Sal B treatment attenuated TGF-β1-induced TβR-I and 
Smad2/3 phosphorylation and up-regulated Smad7 
expression in HK-2 cells
As a mechanistic experiment for the effects of Sal B, we
examined the influence of Sal B on the TGF-β1-Smads
signaling, which is known to play a major role in TGF-β1-
induced EMT. The results demonstrated that there was
no significant change between each group in Smad2/3,
but the expression of phosphorylated Smad2/3 and TβR-I
was significantly increased after incubation with TGF-β1.
Conversely, 1 μM and 10 μM of Sal B as well as SB-
431542 treatments significantly attenuated the TGF-β1-
induced up-regulation of p-Smad2/3 and TβR-I (Figure
11).
Likewise, the expression of Smad7, a negative regulator
of TGF-β1 signaling, was reduced after TGF-β1 stimula-
tion, while 1 μM and 10 μM of Sal B up-regulated its
expression (Figure 11).
Discussion
RIF is the common pathway in chronic renal diseases
regardless of the initial cause. Therefore preventing RIF
could slow down the pace of renal function deterioration
[28]. Recent documents show that hepatocyte growth
factor (HGF), angiotensin-converting enzyme inhibitors
(ACEI), and erythropoietin all could antagonize RIF and
improve renal function [6,29,30]. Traditional Chinese
medicine has a rich history of treating chronic renal dis-
eases over thousands of years, and some herbal medicine
and extracts have proven to contain anti-renal fibrosis
properties both in vivo [31] and in vitro [32]. It is well rec-
ognized that tubular epithelial cells could differentiate
into myofibroblasts via a process referred to as EMT,
which plays a pivotal role in renal interstitial fibrogenesis
[21]. Since specific therapies of preventing the progres-
sion of chronic renal diseases are still lacking, seeking
drug candidates or herbal compounds that can effectively
prevent or inhibit EMT would represent one of the main
strategies in the treatment of RIF.
Tubular EMT is a process during which renal tubular
epithelial cells lose their epithelial phenotype and acquire
new mesenchymal features and consists of four corre-
lated steps with highly regulated mechanisms [21]: (1)
Loss of epithelial cell adhesion through down-regulation
of E-cadherin. (2) De novo α-SMA expression and actin
reorganization, which may provide a structural founda-
tion not only for defining the morphology of the trans-
formed cells, but also for them to migrate, invade, and
even acquire the capacity for contractility. (3) Disruption
of tubular basement membrane, and (4) Enhanced cell
migration and invasion. The latter 2 steps are mainly reg-
ulated by increased activities of MMP-2 and MMP-9
which would specifically break down native type IV colla-
gen and laminin, the principal proteins found in the
TBM, thereby disrupting TBM structural and functional
integrity. Although recent evidence with genetic manipu-
lation indicates that kidney epithelial cells do not become
myofibroblasts in vivo [22], most documents still support
the phenomenon of tubular EMT and its important role
in renal fibrogenesis [21].
In this study, we found that α-SMA expression was
increased significantly around tubules in the fibrotic kid-
ney induced by HgCl2, using immmunohistochemistry
staining, when compared with the normal kidney. In con-
trast, E-cadherin expression decreased around tubular
areas. Although we have not confirmed if these α-SMA
positive tubular cells come from the epithelium or
whether they can synthesize collagen, the increased α-
SMA expression around tubules and MMP-2 activity in
kidney support EMT in vivo. Also, the in vitro results
clearly show that human proximal tubular epithelial cells,
represented by the HK-2 cell line, had undergone EMT
after TGF-β1 incubation, as evidenced by the loss of E-
cadherin, activation of α-SMA, acquisition of a spindle-
like morphology, F-actin re-organization, and an increase
in the activities of MMP2/9. More interestingly, Sal B
could inhibit tubular EMT in fibrotic kidneys, as evi-
denced by the reversal of increased α-SMA and
decreased E-cadherin expression, as well as preventing
renal collagen deposition and fibrosis.
Vit E is a potential antioxidant agent and can prevent
organ fibrosis [33-35]. In our previous study, we found
that chronic mercury intoxication induced RIF with obvi-
ous characteristics of oxidative stress through the deple-
tion of intracellular thiols [20]. Vit E exhibited anti-renal
fibrosis effects through its mechanism of action, which
protects the kidney from oxidative injury. Here we used
Vit E as a control as well, and the results showed that Vit
E also blocked EMT in vivo, but the effects were not as
strong as Sal B. With the EMT cell model induced by
TGF-β1 in HK-2, our data in vitro demonstrated that Sal
B blocked EMT in HK-2 cells, and these results are con-
sistent with our in vivo results as well as in vitro results
from other reports [21]. However, in our experiment, rea-
sonable dosages f Sal B (1 μM and 10 μM) were utilized,
which produced no obvious toxicity, and were used effec-
tively in other experiments [36]. In addition, SB-431542
[37], a potential and specific inhibitor of TβR-I kinase
was used as an active control. The results revealed that
Sal B, as well as SB-431542, significantly reversed EMT
induced by TGF-β1 in HK-2 cells, as evidenced by the
restoration of diminished E-Cadherin and CK-18 expres-
sion, blockage of α-SMA expression, cell morphology
transformation, F-actin reorganization, and down-regu-
lation of MMP-2 and MMP-9 activation. These data notWang et al. BMC Cell Biology 2010, 11:31
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only confirms Sal B's effects in preventing or reversing
tubular EMT in vivo and in vitro, but also implies a mech-
anism of action involved with the regulation of MMP-2/9.
MMP-2/9, in particular MMP-2, have pivotal roles in ini-
tiating renal fibrosis by degrading TBM components and
disrupting its integrity [38]. It was reported that genetic
expression of active MMP-2 in the renal proximal tubule
is sufficient to generate the entire spectrum of EMT in
the absence of superimposed injury. The rat RIF model
induced by HgCl2 displayed a remarkable feature of oxi-
dative stress, which could promote MMP-2 expression
and activity [39]. Our previous studies showed that Sal B
had anti-oxidant effects, and in this study, we found that
Sal B can also inhibit MMP-2 activity in the diseased kid-
ney and subsequently protect tubular basement mem-
brane and prevent EMT and renal fibrosis.
TGF-β1 is the most potent inducer in initiating and
completing the entire EMT course [4]. Its biological
responses are primarily dependent on regulation via the
TβR and Smads signaling pathway. TGF-β1 signals are
transduced by transmembrane serine/threonine kinase
type I and type II receptors, as well as intracellular media-
tors known as Smads [40-42]. Upon TGF-β1 stimulation,
the activated TβR1 associates with R-Smads (Smad2 and
Smad 3) and also phosphorylats them. Such phosphoryla-
tion of Smad-2/3 induces their association with their
common partner Smad4 and subsequent translocation
into the nucleus, where they control the transcription of
TGF-β1 responsive genes [43,44]. As an inhibitory Smad,
Smad 7 prevents or attenuates TGF-β signaling mainly
through interaction with activated TβRI and prevention
of R-Smad phosphorylation.
In this study, we found that the protein expression of
TGF-β1 and TβRI and the phosphorylation levels of
Smad 2 and Smad 3 were significantly increased in the
fibrotic kidney, compared with ones in the normal kidney.
In cultured HK-2 cells, TGF-β1 dramatically up-regulated
TβRI expression and phosphorylated levels of Smad 2
and Smad 3, but down-regulated Smad7 expression, con-
sistent with the data in vivo, and confirmed the character-
istics of TGF-β/Smads signaling in EMT [44]. The down-
regulation of Smad7 protein by TGF-β1 is most likely due
to the promotion of Smad7 degradation [45]. In the rat
model, Sal B and Vit E suppressed TGF-β1 and TβR-I
expression and restored phosphorylation of Smad2 and
Samd3 in fibrotic kidneys. Also, in cultured HK-2 cells,
Sal B and SB-431542 significantly down-regulated the
expression of TβR-I and p-Smad2/3, while restoring the
diminished expression of Smad7 secondary to TGF-β1
stimulation. Although we did not find the action of Sal B
to be dose dependent, the effects of 10 μM of Sal B are
much more prominent than 1 μM of Sal B, and almost
had a similar effect as the SB-431542 inhibitor, indicating
that Sal B can antagonize TβR-I function as well as its
protein expression. The above results indicate that Sal B
can down-regulate TGF-β/Smads signaling pathway, via
suppressing TGF-β1 expression, inhibiting TβR-I expres-
sion and function, down-regulating Smad 2/3 phosphory-
lation, and preventing the down- regulation of Smad7 by
TGF-β1. As stated above, MMP-2 has a role in renal
fibrosis, especially during early pre-fibrotic stage. How-
ever, MMP-2 and MMP-9 are not only stimulated by oxi-
dative stress, but more importantly up-regulated by TGF-
β1 through signal mediators such as Smads and ILK [21].
Our data also showed that MMP-2/9 activities increased
in HK-2 cells after TGF-β1 incubation, but were reversed
by Sal B and SB-431542. Therefore, the TGF-β1/Smads
transduction pathway plays a key role in tubular EMT
and Sal B's pharmacological mechanisms of action
against EMT and renal fibrosis.
Conclusions
Sal B can prevent tubular EMT in both the fibrotic kidney
induced by HgCl2 as well as HK-2 cells triggered by TGF-
β1. The mechanism of action of Sal B is closely related to
the regulation of the TGF-β1 signaling pathway. It func-
tions by inhibiting TGF-β1 expression, suppressing TβR-I
expression and function, down-regulating Smad 2/3
phosphorylation, restoring the down- regulation of
Smad7, and inhibiting the activity of MMP-2.
Methods
Reagents
HgCl2 was purchased from Tongren Chemical Reagent
Factory, Guizhou, China. Vit E was purchased from
Shanghai Yanan Wangxiang Pharmaceutical Co., Ltd,
Shanghai, China. Recombinant human TGF-β1 (reconsti-
tuted with sterile 4 mM HCl containing 1 mg/mL BSA to
a final concentration of 1 μg/mL) was obtained from R&D
Systems, USA. SB-431542, a potent and specific inhibitor
of TβR-I kinase was purchased from TOCRIS Bioscience,
USA. AlarmarBlue™ was purchased from Nalgene Bio-
source International, Camarillo, CA, USA.
The Multiparameter Cytotoxicity 1 Kit was purchased
from Thermo Fisher Scientific, Pittsburgh, PA, USA. Pri-
mary antibodies used in the study are listed in Table 1.
Horseradish peroxidase-conjugated rabbit anti-mouse Ig
and peroxidase-conjugated goat anti-rabbit Ig were
obtained from Chemicon, Temecula, CA, USA. BCA Pro-
tein Assay Kit and SuperSignal West Pico Chemilumines-
cent Substrate were purchased from Pierce Chemical
Company, USA. Cy3-labeled goat Anti-Mouse IgG (H+L)
was provided by the Beyotime Institute of Biotechnology,
Haimen, China. FITC-labeled goat Anti-Mouse IgG
(H+L) was from Invitrogen Corporation, Carlsbad, CA,
USA. RNeasy Mini Kit was purchased from Qiagen,
Valencia, CA, USA. First strand cDNA synthesis kit was
purchased from Fermentas, St. Leon-Roth, Germany.Wang et al. BMC Cell Biology 2010, 11:31
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SYBR Green Real Time PCR Kit was from TakaRa Bio-
tech, Tokyo, Japan. Primer oligonucleotide sequences
specific for the real-time PCR are shown in Table 2,
which were designed and synthesized by Sangon Biotech
Inc, Shanghai, China. Gelatin was purchased from
Amresco, Solon, OH, USA.
Drugs
Sal B was a generous gift from Prof. Da-yuan Zhu at the
Shanghai Institute of Meteria Medica, Chinese Academy
of Science, Shanghai, China. The purity of Sal B was 80%
for the in vivo experiment and 98% for the in vitro experi-
ment. Its molecular weight is 718, and its molecular for-
mula is C36H30O16. The chemical structure of Sal B is
shown in Figure 1. Sal B was dissolved in double distilled
H2O at a concentration of 100 mM, filtered through a
0.22 μm filter, and stored at -70°C.
In Vivo Experimental Design
Fourty-six Sprague-Dawley male rats, weighing 120 ± 10
g (SPF, Certificate No SCXK 2003-0003), were purchased
from the Shanghai Laboratory Animal Center, Chinese
Academy of Sciences. The rats were randomly divided
into 4 groups: Normal (n = 8), Model (n = 12), Sal B
Treatment (Sal B) (n = 14) and Vit E Treatment (Vit E) (n
= 12). The renal interstitial fibrosis model was induced by
the oral administration of HgCl2 a t  a  d os e  o f  8  m g / k g
body weight once a day for 9 weeks [46]. Meanwhile, rats
in the Sal B and Vit E groups were treated with Sal B at a
dose of 10 mg/kg body weight and Vit E at a dose of 100
mg/kg body weight respectively once a day for 9 weeks.
Rats were sacrificed 9 weeks after treatments and the kid-
neys removed. A portion of each kidney was fixed in 10%
phosphate-buffered formalin for histological and immu-
nohistochemical studies after paraffin embedding. The
remainder was snap-frozen in liquid nitrogen and stored
at -80°C for Hyp content determination and protein
extraction. All experimental procedures were carried out
in accordance with internationally accepted laboratory
principles and all animals received humane care during
the study with unlimited access to chow and water.
Examination of Hyp Content in Renal Tissues
Hyp content of kidneys was assayed with HCl hydrolysis
according to Jamall's methods [47]. Briefly, renal tissue
samples weighing 100 mg were homogenized in 2.5 ml of
ice-cold double-distilled water. After determining the
total protein concentration in homogenates, 2 ml of
homogenates were hydrolyzed with HCl (final concentra-
tion = 6 M) at 105°C for 18 h. Hydrolysates were filtered
with 3 mm filter paper and dried at 40°C. The samples
were then incubated with Ehrlich's solution (25% (w/v) p-
Table 1: Antibodies used in the study.
Antibody Isotype Suppliers Cat. No Dilution
α-SMA Mouse IgG2a Sigma A2547 1:200
E-cadherin Mouse IgG2a BD Biosciences 610182 0.25 μg/ml
TGF-β1 mouse IgG1 R&D Systems MAB240 5 μg/ml
TβR-I Rabbit IgG Cell Signaling Technology #3712 1:1000
Smad2 Mouse IgG1 Cell Singaling Technology #3103 1:800
Smad3 Rabbit IgG Zymed Laboratories 51-1500 1:200
CK-18 Mouse IgG1 Chemicon International MAB1600 1:200
p-Smad2 Rabbit IgG1 Cell Singaling Technology #3101 1:200
p-Smad3 Rabbit IgG1 Cell Singaling Technology #9520S 1:200
Smad3 Rabbit IgG Epitomics 1735-1 1:2000
p-Smad3 Rabbit IgG Epitomics 1880-1 1:1000
Smad2 Rabbit IgG Epitomics 1736-1 1:1000
p-Smad2 Rabbit IgG Abcam Ab53100 1:300
Smad7 Rabbit IgG Santa Cruz Biotechnology SC-11392 1:100
Table 2: Primers used for real-time PCR.
Gene Primer sequence (5'-3') Gene bank number Product length
E-cadherin Forward: 5'-CGC CGA GAG CTA CAC GTT CA-3'
Reverse: 5'-TGT CGA CCG GTG CAA TCT TC-3'
NM_004360 93 bp
β-actin Forward: 5'-TGA CGA GGC CCA GAG CAA GA-3'
Reverse: 5'-ATG GGC ACA GTG TGG GTG AC-3'
DQ237887 331 bpWang et al. BMC Cell Biology 2010, 11:31
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dimethylaminobenzaldehyde and 27.3% (v/v) perchloric
acid in isopropanol) at 50°C for 90 minutes and measured
at the absorption of 558 nm (A558). All results were nor-
malized by total protein concentration and calculated
using a standard curve.
Histologic Examination
The kidneys fixed in 10% phosphate-buffered formalin
were embedded in paraffin and sectioned (3 μM thick-
ness). The sections were then stained with Masson
trichrome to assess for collagen fiber deposition.
Immunohistochemical Examination
3 μm-thick sections were used for immunohistochemical
examination. These sections were digested with pepsin at
37°C for 20 min, followed by incubation with 0.1% BSA in
PBS for 30 min, and then incubated again with primary
antibodies against E-cadherin (1:50) or α-SMA (1:100) at
37°C for 1 h. The sections were then incubated with
FITC- or Cy3-labeled second antibodies at 37°C for 1 h,
and images were obtained with a fluorescent microscope
(Olympus).
Cell Culture and Treatment
H K - 2  c e l l s  w e r e  o b t a i n e d  f r o m  t h e  I n s t i t u t e  o f  B a s i c
Medical Sciences Chinese Academy of Medical Sciences,
and maintained in Dulbecco's modified Eagle's medium
(DMEM) supplemented with 5% fetal bovine serum
(FBS), 100 units/ml of penicillin, and 100 units/ml of
streptomycin. The cells were cultured with 5% CO2 at
9 5 %  h u m i d i t y .  H K - 2  c e l l s  w e r e  c u l t u r e d  i n  c o m p l e t e
medium containing 5% FBS for 18 h. Thereafter, the cells
were kept in serum-free medium or treated with (1) 2.5
ng/ml TGF-β1, (2) 2.5 ng/ml TGF-β1 plus 1 μM of Sal B,
(3) 2.5 ng/ml TGF-β1 plus 10 μM of Sal B, or (4) 2.5 ng/ml
TGF-β1 plus 10 μM of SB-431542 for 24 h.
Cell Viability Assay
To determine cell viability, HK-2 cells were seeded at a
density of 3,000 cells per well in 96-well cell culture
plates. After growing for 18 h under normal growth con-
ditions, the medium was replaced with DMEM contain-
ing different concentrations of Sal B and 10% alamarBlue
(AB) solution. As a negative control, AB was added to the
medium without cells. Medium only was used as blank
control. The absorbance of test and control wells was
read at 570 and 600 nm using a microplate reader
(Molecular Devices) after 4 h, 12 h, and 24 h of incuba-
tion. The calculation of the percentage of AB reduction
(%AB reduction) is as follows:
In the formula, A 570 and A 600 represent the absor-
bance of test wells at 570 and 600 nm, respectively. #A570
and #A600 represent the absorbance of negative control
wells at 570 and 600 nm, respectively. *A570 and *A600
represent the absorbance of blank control wells at 570
and 600 nm, respectively.
Assessment of cytotoxicity of Sal B with high content 
screening (HCS) assay
The cytotoxicity of Sal B on HK-2 cells was determined
with the Multiparameter Cytotoxicity Kit 1. The principle
of the assay is that live cells are labeled with a cocktail of
fluorescent dyes that indicate the cellular properties of
interest: (1) nucleus and its size, (2) cell membrane per-
meability status, (3) lysosome and other acidic organelles'
pH and mass. All procedures were conducted according
to the manufacturer's instruction. HK-2 cells were seeded
at a density of 4 × 104 cells/ml in DMEM Medium plus 5%
FBS in individual wells within a 96-well plate (approxi-
mately 4,000 cells/well). After culturing for 18 h, cells
were incubated with 1 μM, 10 μM, or 100 μM of Sal B in
serum-free DMEM for another 24 h. At 30 min before the
completion of incubation, 1× MPCT1 Fluor Solution was
added to each well. Then cells were fixed with pre-
warmed Fixation Solution and washed twice with PBS.
The plate was sealed and read with a HCS Kinetic Scan
(Cellomics) immediately to acquire images.
RNA Isolation, cDNA Synthesis, and Real-time RT-PCR
HK-2 cells were cultured in complete medium containing
5% FBS for 18 h. Thereafter, the cells were kept in serum-
free medium or treated with (1) 2.5 ng/ml TGF-β1, (2) 2.5
ng/ml TGF-β1 plus 1 μM of Sal B, (3) 2.5 ng/ml TGF-β1
plus 10 μM of Sal B, or (4) 2.5 ng/ml TGF-β1 plus 10 μM
of SB-431542 for 24 h.
Total cellular RNA was isolated using RNeasy Mini Kit
according to the manufacturer's protocol. RNA concen-
tration was determined spectrophotometrically, and its
integrity was checked by agarose gel electrophoresis.
cDNA was generated using 4 μg of total RNA in a final
r ea ct ion vo lum e  o f  20 μ l by  t he  R ev ert Aid firs t -s t ra nd
cDNA synthesis kit according to the manufacturer's pro-
tocol. Quantitative Real-time PCR was performed with a
Rotor-gene 3000. Primers along with their sequences are
listed in Table 2. PCR mixtures contained 1 μl of cDNA,
10 μl of SYBR® Premix Ex Taq 2× and 0.25 μmol/L of for-
ward and reverse primers, for a total volume of 20 μl.
Reactions were started with a polymerase activation step
at 95°C for 10 s followed by 40 cycles of 95°C for 5 s, 58°C
for 15 s and 72°C for 10 s. Fluorescent data were acquired
after each cycle. The absence of primer dimmers and
non-specific products were verified after each run by
melting curve analysis. The PCR mixture's relative quan-
tity was calculated using a standard curve.
%ABReduction
117.2 (A570 #A570) 80.5 (A600 #A600)
155.7 (*A
=
××
×
−− −
5 570 #A570) 14.6 (*A600 #A600) −− − ×
×100Wang et al. BMC Cell Biology 2010, 11:31
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Immunocytochemical Staining
Indirect immunofluorescence staining was performed.
Briefly, HK-2 cells cultured on coverslips were washed
with cold PBS twice and fixed with a cold mixture of
methanol: acetone (1:1) for 10 min on ice. After extensive
washing with PBS three times, the cells were permeated
with 0.05% saponin for 15 min. The cells were then
blocked with 5% bovine serum albumin in PBS buffer for
30 min at room temperature before incubation with pri-
mary antibodies against α-SMA (1:100) or CK-18 (1:100).
To visualize the primary antibodies, cells were stained
with FITC-conjugated secondary antibodies. After wash-
ing, cells were doublestained with Hoechst 33258 to visu-
alize the nuclei. Stained cells were mounted with antifade
mounting medium and viewed with a fluorescence
microscope (Olympus).
Western Blot Analysis
Kidney tissue and HK-2 cells were homogenized in lysis
buffer (150 mM NaCl, 1% Nonidet P-40, 0.1% SDS, 50
mM Tris-HCl pH7.4, 1 mM EDTA, 1 mM PMSF, 1×
Roche complete mini protease inhibitor cocktail, Roche
PhosSTOP phosphatase inhibitor cocktail). The superna-
tants were collected after centrifugation at 10,000 g at 4°C
for 15 min. Protein concentration was determined using a
BCA protein assay kit. Equal amounts of protein were
separated by 10% SDS gel electrophoresis (SDS-PAGE)
under denaturing and non-reducing conditions and then
transferred to a nitrocellulose membrane. The membrane
was blocked with 5% nonfat milk in TBST at room tem-
perature for 1 h and then incubated with primary anti-
body (Table 1) at 4°C overnight. After washing in TBST,
the blots were incubated with horseradish-coupled sec-
ondary antibody. The signals were visualized using
enhancence chemical luminescent (ECL) system.
Gelatinase Activity Assay
MMPs activity in the kidney tissue and supernatant of
cultured cells was assayed by gelatin zymography. Briefly,
the kidney tissue was homogenized in lysis buffer (1 M
Tris-HCl, 0.5 M NaCl, pH 7.0), the homogenate was cen-
trifuged at 12000 × g for 30 min. For supernatant of cul-
tured cells, conditioned media were collected and
centrifuged at 13,000 × g for 5 min to remove any cell
debris. The protein concentration was determined using
a BCA protein assay kit. Aliquots of protein (15 μg pro-
tein/lane) were prepared by dilution into zymogram sam-
ple buffer (5×) consisting of 0.4 M Tris, pH 6.8, 5% SDS,
20% glycerol and 0.03% bromphenol blue. They were then
separated by electrophoresis in 10% SDS-PAGE contain-
ing 1 mg/ml gelatin as a substrate in non-reducing condi-
tions. After this process, the gel was rinsed with 50 mM
Tris- HCl, 5 mM CaCl2, 1 μM ZnCl2 and 2.5% Triton-X
100 (pH 7.5) to remove SDS and then incubated at 30°C
for 18 h with the same buffer minus Triton-X 100. After
incubation, the gel was stained with 0.1% Coomassie Bril-
liant Blue G-250 in 30% methanol/20% acetic acid and
destained with 30% methanol/10% acetic acid. Areas of
digestion are visualized as non-staining regions of the gel,
which represent gelatinase activity. The gel was scanned,
and gelatinolytic activity was analyzed using Furi Gel
Image software (Furi, Shanghai, China).
Statistical Analysis
Values are expressed as mean ± SE. Statistical analyses
were carried out using the one-way analysis of variance
(ANOVA) followed by the least significant difference
(LSD) post-hoc test. Values of P < 0.05 were considered
significant.
Abbreviations
α-SMA: alpha smooth muscle actin; AB: alamarBlue; ACEI: angiotensin-convert-
ing enzyme inhibitors; ANOVA: one-way analysis of variance; CK-18: Cytokera-
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mesenchymal transition; FBS: fetal bovine serum; HCS: high content screening;
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cells; LSD: the least significant difference; MMPs: Matrix metalloproteinases; RIF:
Renal interstitial fibrosis; ROS: reactive oxygen species; Sal B: Salvianolic Acid B;
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